The United States and Norway co-hosted a meeting of GAVI Alliance donors and partners on 6 October 2010 in New York
The Governments of the United States and Norway co-hosted a high-level meeting of GAVI Alliance donors, potential donors and partners in New York on 6 October to build on GAVI's cost-effective success in preventing 5.4 million deaths in its first 10 years.
GAVI Alliance partners agreed on action to avert an estimated 4.2 million future deaths through immunisation. The meeting also set the outline for a pledging meeting in 2011. GAVI needs to raise US$4.3 billion to scale-up immunisation programmes between 2010 and 2015.
The funding that GAVI is requesting would, in part, pay for the introduction of new vaccines to tackle major causes of the world's two biggest childhood killers, pneumonia and diarrhoea, as well as advance the introduction of new vaccines against HPV, Japanese encephalitis, meningitis serogroup A, rubella and typhoid.
The investment will also ensure the sustainability of the pentavalent vaccine to accelerate DTP coverage, while also protecting children against Hepatitis B and Hib.
Investments in immunisation and in the GAVI Alliance are among the best value for money in global health. Every dollar invested in GAVI programmes will move the international community closer to achieving the goals of the G8 leaders' recent Muskoka Initiative, designed to improve maternal, new born and child health. The G8 has agreed that funding to GAVI counts 100 percent towards the Muskoka Initiative.
With the funding in place, GAVI estimates it can save a projected 4.2 million lives in developing countries over the next four years thereby helping to achieve Millennium Development Goal 4 which aims to reduce under-five mortality by two-thirds by 2015.
The GAVI Call for Action and Resources meeting followed on from the High-Level Meeting on Financing Country Demand in The Hague in March 2010 at which donors were presented with compelling evidence of the cost-effectiveness of immunisation as a means to improve health and achieve the Millennium Development Goals.
Graça Machel, told the meeting in The Hague that it was unconscionable to leave millions of children at risk of disease and death, while infants in rich nations receive life-saving vaccines.
"We have the chance to make the world a fairer place and give children of Africa, Asia and Latin America the chance to a healthy life and contribute to the future prosperity of their communities and countries. This is a job worth doing. It is a mission worth completing," she said.
5.4 million lives saved in first decade
Thanks to strong donor support, GAVI invested nearly US$ 5 billion over the past decade to accelerate access to immunisation and help reduce under-five mortality.
This enabled the Alliance to reach 257 million children with vaccines and save 5.4 million lives in its first decade of operations.
Immunisation as cost-effective foundation
For every man, woman and child whose premature death is averted as a result of childhood immunisation, millions more are protected from common but preventable diseases enabling them to lead healthy and productive lives. Immunisation is a highly-cost-effective foundation for strong communities and economies.
GAVI support to developing countries will be significantly reduced if this funding is provided as annual, ad hoc contributions, rather than the more predictable long-term funding that is critical to multi-year immunisation programmes.
Chair's summary from HLM on Financing Country Demand
List of participants
Impact, value and effectiveness
Financing country demand for accelerated access to new and underused vaccines, 2010-2015
Comparision of contribution models
Investing in immunisation through the GAVI Alliance: the evidence base